Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Cogent Biosciences, Inc. (COGT), most recent 12 months reported: net loss $377.18M, free cash flow -$309.24M. Latest balance sheet on file: liquid cash $792.3M, total debt $223.46M, net cash $568.84M. From SEC filings. More on Cogent Biosciences, Inc.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: CNBX PHARMACEUTICALS INC. · CNS Pharmaceuticals, Inc. · CONTEXT THERAPEUTICS INC. · COCRYSTAL PHARMA, INC. · Corbus Pharmaceuticals Holdings, Inc. · Corvus Pharmaceuticals, Inc. · Contineum Therapeutics, Inc. · Citius Oncology, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.